Platelet microparticles (PMPs) are vesicles that are released by platelets into the
extracellular space and play a role in antiphospholipid antibody syndromes. PMPs have …

Abstract Anti‑β 2‑glycoprotein I (anti‑β 2 GPI) is an anti‑phospholipid antibody that
specifically binds to β 2 GPI. There is growing evidence that this autoantibody is closely …

Platelet microparticles (MPs) are membrane vesicles shed by platelets after activation, and
carry antigens characteristic of intact platelets, such as glycoprotein (GP) IIb/IIIa, GPIb and P …

Background Patients with anti-β2GPI antibodies display significantly higher platelet
activation/aggregation and vascular endothelial cell damage. The mechanism underlying …

Platelet-derived microparticles (PMPs) are released from platelets through the platelet
activation by high shear stress, collagen, or calcium ionophore (A23187). PMPs are …

Antiphospholipid syndrome is an autoimmune disease characterized by the persistent
presence of antiphospholipid antibodies, along with occurrence of vascular thrombosis and …

Microparticles released from platelets (PMPs) may play a role in the normal hemostatic
response to vascular injury because they demonstrate prothrombinase activity. PMPs were …

Platelet-derived microparticles (PMPs) are a type of microparticle budding from platelets
undergoing activation or apoptosis in many autoimmune diseases, including …

There is increasing research on and clinical interest in the physiological role played by
platelet microparticles (PMPs). PMPs are 0.1–1-μm fragments shed from plasma …

Described 40 years ago as cell dust, microparticles (MPs) are now considered a key
component in the haemostatic response. Owing to their plasma membrane reactivity …